RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 84 filers reported holding RAPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $8,175,894 | -66.0% | 2,680,621 | 0.0% | 11.47% | -23.5% |
Q1 2024 | $24,071,977 | -63.9% | 2,680,621 | 0.0% | 14.99% | -65.9% |
Q4 2023 | $66,613,432 | +49.5% | 2,680,621 | 0.0% | 44.00% | +48.8% |
Q3 2023 | $44,551,921 | -11.1% | 2,680,621 | 0.0% | 29.58% | +52.1% |
Q2 2023 | $50,127,613 | +1.9% | 2,680,621 | 0.0% | 19.45% | +9.4% |
Q1 2023 | $49,189,395 | -7.3% | 2,680,621 | 0.0% | 17.79% | +0.7% |
Q4 2022 | $53,076,296 | -17.7% | 2,680,621 | +0.0% | 17.67% | +23.8% |
Q3 2022 | $64,492,000 | +31.8% | 2,680,458 | 0.0% | 14.27% | +37.1% |
Q2 2022 | $48,918,000 | +58.7% | 2,680,458 | +91.2% | 10.41% | +82.1% |
Q1 2022 | $30,830,000 | -40.1% | 1,402,008 | 0.0% | 5.72% | -18.4% |
Q4 2021 | $51,496,000 | +18.3% | 1,402,008 | 0.0% | 7.00% | +41.4% |
Q3 2021 | $43,532,000 | -64.8% | 1,402,008 | -63.9% | 4.95% | -71.7% |
Q2 2021 | $123,526,000 | +43.2% | 3,885,679 | 0.0% | 17.48% | +111.5% |
Q1 2021 | $86,262,000 | +12.4% | 3,885,679 | 0.0% | 8.26% | +18.7% |
Q4 2020 | $76,742,000 | – | 3,885,679 | – | 6.96% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Column Group LLC | 2,680,621 | $53,076,296 | 17.67% |
Euclidean Capital LLC | 432,900 | $8,571,420 | 8.02% |
GREAT POINT PARTNERS LLC | 1,436,569 | $28,444,066 | 5.58% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 880,000 | $17,424,000 | 3.47% |
Trustees of Columbia University in the City of New York | 73,383 | $1,453 | 3.00% |
Cheyne Capital Management (UK) LLP | 71,828 | $1,422,194 | 2.48% |
Deep Track Capital, LP | 1,304,940 | $25,837,812 | 1.08% |
Ghost Tree Capital, LLC | 125,000 | $2,475,000 | 1.06% |
Perceptive Advisors | 1,798,955 | $35,619,309 | 1.00% |
BRAIDWELL LP | 1,000,000 | $19,800,000 | 0.66% |